706 related articles for article (PubMed ID: 18648016)
1. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.
Mann D; Reynolds K; Smith D; Muntner P
Ann Pharmacother; 2008 Sep; 42(9):1208-15. PubMed ID: 18648016
[TBL] [Abstract][Full Text] [Related]
2. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.
Hyre AD; Muntner P; Menke A; Raggi P; He J
Ann Epidemiol; 2007 Jul; 17(7):548-55. PubMed ID: 17395483
[TBL] [Abstract][Full Text] [Related]
3. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
Bradford WD; Kleit AN; Nietert PJ; Ornstein S
Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
[TBL] [Abstract][Full Text] [Related]
4. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
[TBL] [Abstract][Full Text] [Related]
5. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
6. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
Ghandehari H; Kamal-Bahl S; Wong ND
Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
[TBL] [Abstract][Full Text] [Related]
9. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
10. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
[TBL] [Abstract][Full Text] [Related]
11. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.
Cullen MW; Stein JH; Gangnon R; McBride PE; Keevil JG
Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658
[TBL] [Abstract][Full Text] [Related]
12. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.
Michos ED; Blumenthal RS
J Am Coll Cardiol; 2009 Mar; 53(11):931-5. PubMed ID: 19281922
[TBL] [Abstract][Full Text] [Related]
14. Statin treatment and adherence to national cholesterol guidelines after ischemic stroke.
Ovbiagele B; Saver JL; Bang H; Chambless LE; Nassief A; Minuk J; Toole JF; Crouse JR;
Neurology; 2006 Apr; 66(8):1164-70. PubMed ID: 16636231
[TBL] [Abstract][Full Text] [Related]
15. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
16. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey.
Hickman TB; Briefel RR; Carroll MD; Rifkind BM; Cleeman JI; Maurer KR; Johnson CL
Prev Med; 1998; 27(6):879-90. PubMed ID: 9922071
[TBL] [Abstract][Full Text] [Related]
17. Exploring the gap between National Cholesterol Education Program guidelines and clinical practice in secondary care: results of a cross-sectional study involving over 10 000 patients followed in different specialty settings across Italy.
Rapezzi C; Biagini E; Bellis P; Cafiero M; Velussi M; Ceriello A; Cooke RM; Schweiger C;
J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):878-87. PubMed ID: 18695423
[TBL] [Abstract][Full Text] [Related]
18. Dyslipidemias and HMG-CoA reductase inhibitor prescription in heart transplant recipients.
de Denus S; Al-Jazairi A; Loh E; Jessup M; Stanek EJ; Spinler SA
Ann Pharmacother; 2004; 38(7-8):1136-41. PubMed ID: 15150383
[TBL] [Abstract][Full Text] [Related]
19. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):109-14. PubMed ID: 21293326
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol: precursor to many lipid disorders.
Jones PH
Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
